Effect of Ramipril on Left Ventricular Mass in Normotensive Hemodialysis Patients

Conclusion: A 12-month treatment with ramipril did not cause significant regression of left ventricular hypertrophy in normotensive hemodialysis patients. Results may suggest that the renin-angiotensin system has little role in the pathogenesis of mild left ventricular hypertrophy in these patients.